BioArctic Financial Statements From 2010 to 2025
| BRCTF Stock | 34.74 0.12 0.35% |
Check BioArctic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioArctic's main balance sheet or income statement drivers, such as , as well as many indicators such as . BioArctic financial statements analysis is a perfect complement when working with BioArctic Valuation or Volatility modules.
BioArctic |
BioArctic AB Company Current Valuation Analysis
BioArctic's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BioArctic Current Valuation | 2.53 B |
Most of BioArctic's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioArctic AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BioArctic AB has a Current Valuation of 2.53 B. This is 82.36% lower than that of the Healthcare sector and 45.44% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 84.75% higher than that of the company.
BioArctic AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioArctic's current stock value. Our valuation model uses many indicators to compare BioArctic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioArctic competition to find correlations between indicators driving BioArctic's intrinsic value. More Info.BioArctic AB is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioArctic's earnings, one of the primary drivers of an investment's value.About BioArctic Financial Statements
BioArctic stakeholders use historical fundamental indicators, such as BioArctic's revenue or net income, to determine how well the company is positioned to perform in the future. Although BioArctic investors may analyze each financial statement separately, they are all interrelated. For example, changes in BioArctic's assets and liabilities are reflected in the revenues and expenses on BioArctic's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BioArctic AB. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in BioArctic Pink Sheet
BioArctic financial ratios help investors to determine whether BioArctic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioArctic with respect to the benefits of owning BioArctic security.